[Fudan Fuhua: holding subsidiary bicalutamide tablets pass generic drug consistency evaluation] Fudan Fuhua announcement, Fudan Fuhua announcement, Fudan Fuhua Pharmaceutical Co., Ltd. passed generic drug consistency evaluation of bikalutamide tablets. Bicalutamide has been widely used in the treatment of prostate cancer at all stages and is the first line of endocrine therapy for prostate cancer.